Pharmacoinformatics-enabled Interventions Improved Care Coordination and Identified Pharmacy-Related Safety Issues in a Multicultural Medicare Population

Abstract

Background Compared to White populations, multicultural older adults experience more gaps in preventive care (e.g., vaccinations, screenings, chronic condition monitoring), social determinants of health barriers (e.g., access to care, language, transportation), and disparities and inequities (e.g., comorbidities, disease burden, and health care costs).

Objectives This study aims to describe an informatics-based approach used to execute and evaluate results of a member-centric, pharmacoinformatics-informed engagement program to deliver culturally tailored microinterventions to close medication-related gaps in care utilizing multidisciplinary care coordination that leverages the expanded role of the pharmacist. The operational framework will be described, and the influence of the medication use processes will be reported in a multicultural Medicare Advantage cohort.

Methods A pharmacoinformatics framework was leveraged to conduct a retrospective, observational cohort analysis of the program. Claims data were used to evaluate the influence of medication use process microinterventions from a large Medicare Advantage cohort of members who self-identify as Black and/or Hispanic, and have type 2 diabetes mellitus and/or hypertension, and meet eligibility criteria for multidisciplinary (e.g., nursing and pharmacy) care management (CM) and received pharmacy referral from January 1, 2022, through September 30, 2023.

Results A total of 3,265 Medicare Advantage members (78.3% Black and 21.7% Hispanic) received CM and pharmacy referral. Pharmacovigilance reviews conducted during this timeframe identified 258 acute events that escalated member CM. Provider outreach (n = 185) informed of safety issues (drug duplication, n = 48; drug interactions, n = 21; drug–disease interactions, n = 5; noncompliance and/or dosing issues, n = 27). Outreach to members (n = 160) and providers (n = 164) informed of open quality-related measure gaps for medication adherence.

Conclusion The application of pharmacoinformatics by a payor-led multicultural clinical program demonstrated quality improvements in Medicare Advantage member identification including risk stratification, timely outreach for pharmacy-related safety issues, and improved efficiency of multidisciplinary care coordination involving medication use process workflows.

Keywords

aged - medication adherence - medication therapy management - clinical informatics - chronic disease

• References

• 1 Craig KJT, Bright TJ, Karunakaram H. et al. HPR55 How inequities and disparities in health & healthcare are impacting COVID-19 outcomes: a scoping review. Value Health 2022; 25 (07) S476
• 2 Lopez III L, Hart III LH, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA 2021; 325 (08) 719-720
• 3 2021 National Healthcare Quality and Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; ; December 2021. Accessed February 2, 2024 at https://www.ncbi.nlm.nih.gov/books/NBK578529/
• 4 Ashton CM, Haidet P, Paterniti DA. et al. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?. J Gen Intern Med 2003; 18 (02) 146-152
• 5 Martinez ML, Coles S. Addressing immunization health disparities. Prim Care 2020; 47 (03) 483-495
• 6 Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Community Health 2017; 42 (05) 1044-1061
• 7 White RO, Beech BM, Miller S. Health care disparities and diabetes care: practical considerations for primary care providers. Clin Diabetes 2009; 27 (03) 105-112
• 8 Cheng CY, Reich D, Haiman CA. et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS ONE 2012; 7 (03) e32840
• 9 Florez JC, Price AL, Campbell D. et al. Strong association of socioeconomic status with genetic ancestry in Latinos: implications for admixture studies of type 2 diabetes. Diabetologia 2009; 52 (08) 1528-1536
• 10 Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis 2007; 17 (01) 143-152
• 11 Herman WH, Ma Y, Uwaifo G. et al; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30 (10) 2453-2457
• 12 Thomas Craig KJ, Fusco N, Lindsley K. et al. Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities. Cardiovasc Digit Health J 2020; 1 (03) 139-148
• 13 Centers for Disease Control and Prevention. NCCDPHP Health Equity Glossary. Accessed February 8, 2024 at: https://www.cdc.gov/chronicdisease/healthequity/health-equity-communications/nccdphp-health-equity-glossary.html
• 14 Bobo WV, Yawn BP, St Sauver JL, Grossardt BR, Boyd CM, Rocca WA. Prevalence of combined somatic and mental health multimorbidity: patterns by age, sex, and race/ethnicity. J Gerontol A Biol Sci Med Sci 2016; 71 (11) 1483-1491
• 15 Quiñones AR, Liang J, Bennett JM, Xu X, Ye W. How does the trajectory of multimorbidity vary across Black, White, and Mexican Americans in middle and old age?. J Gerontol B Psychol Sci Soc Sci 2011; 66 (06) 739-749
• 16 Hanlon C, Hinkle L. Assessing the costs of racial and ethnic health disparities: state experience. Rockville, MD: Healthcare Cost and Utilization Project (HCUP); ; June 2011
• 17 Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health 1997; 87 (10) 1626-1629
• 18 Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287 (03) 337-344
• 19 Centers for Medicare & Medicaid Services. Medication Therapy Management. 2023 . Accessed October 24, 2023 at: https://www.cms.gov/medicare/coverage/prescription-drug-coverage-contracting/medication-therapy-management
• 20 Tajchman S, Lawler B, Spence N, Haque S, Quintana Y, Ateya M. Implementation and use of risk evaluation and mitigation strategies programs in practice: a scoping review of the literature. Appl Clin Inform 2022; 13 (05) 1151-1160
• 21 Baquet-Simpson AM, Craig KJT, MacKenzie SM. et al. Spotlight: a phased Medicare engagement to close gaps in preventive care for Black and Hispanic populations with type 2 diabetes mellitus and/or hypertension. J Health Care Poor Underserved 2022; 33 (05) 1-6
• 22 U.S. Department of Health and Human Services. About the Affordable Care Act. Accessed October 24, 2023 at: https://www.hhs.gov/healthcare/about-the-aca/index.html
• 23 Thompson CA. New health care laws will bring changes for pharmacists. Am J Health Syst Pharm 2010; 67 (09) 690-695
• 24 Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens 2010; 23 (09) 949-955
• 25 Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010; (03) CD004371
• 26 Jolivot PA, Hindlet P, Pichereau C. et al. A systematic review of adult admissions to ICUs related to adverse drug events. Crit Care 2014; 18 (06) 643
• 27 Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42 (07) 1017-1025
• 28 Agency for Healthcare Research and Quality. Medication Errors and Adverse Drug Events. 2019 . Accessed October 24, 2023 at: https://psnet.ahrq.gov/primer/medication-errors-and-adverse-drug-events
• 29 Pedrós C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol 2014; 70 (03) 361-367
• 30 Zhang T, Gephart SM, Subbian V. et al. Barriers to adoption of tailored drug-drug interaction clinical decision support. Appl Clin Inform 2023; 14 (04) 779-788